Prediction of Cancer Incidence and Mortality in Korea, 2023 - PubMed (original) (raw)
Prediction of Cancer Incidence and Mortality in Korea, 2023
Kyu-Won Jung et al. Cancer Res Treat. 2023 Apr.
Abstract
Purpose: This study aimed to report the projected cancer incidence and mortality for the year 2023 to estimate Korea's current cancer burden.
Materials and methods: Cancer incidence data from 1999 to 2020 were obtained from the Korea National Cancer Incidence Database, and cancer mortality data from 1993 to 2021 were acquired from Statistics Korea. Cancer incidence and mortality were projected by fitting a linear regression model to observed age-specific cancer rates against their respective years and then by multiplying the projected age-specific rates by the anticipated age-specific population for 2023. A joinpoint regression model was used to determine the year in which the linear trend changed significantly; we only used the data of the latest trend.
Results: In total, 273,076 new cancer cases and 81,818 cancer deaths are expected to occur in Korea in 2023. The most common cancer site is expected to be the lung, followed by the thyroid, breast, colon and rectum, and stomach. These five cancers are expected to represent half of the overall burden of cancer in Korea. The most common type of cancer leading to death is expected to be lung cancer, followed by liver, colorectal, pancreatic, and gallbladder cancers.
Conclusion: The incidence rates for all types of cancer in Korea are estimated to gradually decrease. These up-to-date estimates of the cancer burden in Korea could be an important resource for planning and evaluating cancer-control programs.
Keywords: 2023; Forecasting; Incidence; Korea; Mortality; Neoplasms.
Conflict of interest statement
Conflicts of Interest
Conflict of interest relevant to this article was not reported.
Figures
Fig. 1
The 10 leading types of estimated new cancer cases and deaths by sex in 2023. (A) Estimated new cases. (B) Estimated deaths.
Fig. 2
Projected age-specific incidences of major cancers during 2023 in Korea. (A) Men. (B) Women.
Fig. 3
Projected age-specific mortality rates of major cancers during 2023 in Korea. (A) Men. (B). Women.
Similar articles
- Prediction of Cancer Incidence and Mortality in Korea, 2022.
Jung KW, Won YJ, Kang MJ, Kong HJ, Im JS, Seo HG. Jung KW, et al. Cancer Res Treat. 2022 Apr;54(2):345-351. doi: 10.4143/crt.2022.179. Epub 2022 Mar 21. Cancer Res Treat. 2022. PMID: 35313101 Free PMC article. - Prediction of Cancer Incidence and Mortality in Korea, 2021.
Jung KW, Won YJ, Hong S, Kong HJ, Im JS, Seo HG. Jung KW, et al. Cancer Res Treat. 2021 Apr;53(2):316-322. doi: 10.4143/crt.2021.290. Epub 2021 Mar 17. Cancer Res Treat. 2021. PMID: 33735558 Free PMC article. - Prediction of Cancer Incidence and Mortality in Korea, 2024.
Jung KW, Kang MJ, Park EH, Yun EH, Kim HJ, Kim JE, Kong HJ, Im JS, Seo HG. Jung KW, et al. Cancer Res Treat. 2024 Apr;56(2):372-379. doi: 10.4143/crt.2024.252. Epub 2024 Mar 11. Cancer Res Treat. 2024. PMID: 38487833 Free PMC article. - Attributable fraction of tobacco smoking on cancer using population-based nationwide cancer incidence and mortality data in Korea.
Park S, Jee SH, Shin HR, Park EH, Shin A, Jung KW, Hwang SS, Cha ES, Yun YH, Park SK, Boniol M, Boffetta P. Park S, et al. BMC Cancer. 2014 Jun 6;14:406. doi: 10.1186/1471-2407-14-406. BMC Cancer. 2014. PMID: 24902960 Free PMC article. Review. - Cancer statistics, 2004.
Jemal A, Tiwari RC, Murray T, Ghafoor A, Samuels A, Ward E, Feuer EJ, Thun MJ; American Cancer Society. Jemal A, et al. CA Cancer J Clin. 2004 Jan-Feb;54(1):8-29. doi: 10.3322/canjclin.54.1.8. CA Cancer J Clin. 2004. PMID: 14974761 Review.
Cited by
- An Antagonist Antibody That Inhibits Cancer Cell Growth In Vitro through RACK1.
Kim JH, Lee EJ, Han KH. Kim JH, et al. Pharmaceuticals (Basel). 2024 Sep 30;17(10):1303. doi: 10.3390/ph17101303. Pharmaceuticals (Basel). 2024. PMID: 39458945 Free PMC article. - Modified Albumin-Bilirubin Grade After Curative Treatment: Predicting the Risk of Late Intrahepatic Recurrence of Hepatocellular Carcinoma.
Goh MJ, Park HC, Kim N, Bae BK, Choi MS, Rhu J, Lee MW, Jeong WK, Kim M, Kim K, Yu JI. Goh MJ, et al. J Korean Med Sci. 2024 Sep 30;39(37):e251. doi: 10.3346/jkms.2024.39.e251. J Korean Med Sci. 2024. PMID: 39355950 Free PMC article. - Risk factor analysis and establishment of a predictive model for complications of elderly advanced gastric cancer with Clavien-Dindo classification ≥ II grade.
Liu ZK, Ma WX, Zhang JJ, Liu SD, Duan XL, Wang ZZ. Liu ZK, et al. BMC Cancer. 2024 Sep 27;24(1):1185. doi: 10.1186/s12885-024-12965-5. BMC Cancer. 2024. PMID: 39333976 Free PMC article. - Fish and meat intake in relation to colorectal adenoma in asymptomatic Korean adults.
Kim YS, Okekunle AP, Yang SY, Song JH, Youn J, Kwon GYJ, Lee JE. Kim YS, et al. Front Nutr. 2024 Sep 4;11:1432647. doi: 10.3389/fnut.2024.1432647. eCollection 2024. Front Nutr. 2024. PMID: 39296502 Free PMC article. - Extraperitoneal single-port robot-assisted radical prostatectomy: Short-term outcomes and technique description.
Kwon HJ, Kang S, Rhew SA, Yoon CE, Shin D, Bang S, Moon HW, Bae WJ, Cho HJ, Ha US, Lee JY, Kim SW, Hong SH. Kwon HJ, et al. Investig Clin Urol. 2024 Sep;65(5):442-450. doi: 10.4111/icu.20230427. Investig Clin Urol. 2024. PMID: 39249916 Free PMC article.
References
- Statistics Korea [Internet] Daejeon: Statistics Korea; 2023. [cited 2023 Feb 8]. Available from: http://kosis.kr.
- Fritz A, Percy C, Jack A, Shanmugaratnam K, Sobin L, Parkin DM, et al. International classification of diseases for oncology. 3rd ed. . Geneva: World Health Organization; 2013. 1st rev.
- World Health Organization . International statistical classification of diseases and related health problems. 10th rev. . Geneva: World Health Organization; 1994.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical